Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Ozurdex for Combined Pseudophakic Cystoid Macula Edema and Diabetic Macula Edema After Cataract Surgery

NCT01284478 is registered in ClinicalTrials.gov with Northern California Retina Vitreous Associates as lead sponsor.

NCT NCT01284478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01284478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Ozurdex for Combined Pseudophakic Cystoid Macula Edema and Diabetic Macula Edema After Cataract Surgery
Lead sponsor
Northern California Retina Vitreous Associates
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
October 31, 2012
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, pseudophakic cystoid macular edema,